Biological impact of iberdomide in patients with active systemic lupus erythematosus | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Systemic lupus erythematosus

Biological impact of iberdomide in patients with active systemic lupus erythematosus

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

	Abstract	Full	Pdf
Apr 2022	288	299	108
May 2022	1026	995	298
Jun 2022	435	381	154
Jul 2022	777	771	228
Aug 2022	360	353	148
Sep 2022	206	209	108
Oct 2022	186	166	106
Nov 2022	137	122	63
Dec 2022	123	109	77
Jan 2023	147	129	59
Feb 2023	139	126	55
Mar 2023	156	144	76
Apr 2023	85	80	53
May 2023	133	120	52
Jun 2023	149	139	72
Jul 2023	75	62	43
Aug 2023	82	62	47
Sep 2023	62	54	36
Oct 2023	72	61	34
Nov 2023	76	63	43
Dec 2023	89	77	39
Jan 2024	75	60	46
Feb 2024	77	68	27
Mar 2024	71	69	64
Total	5026	4719	2036